BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis
Clinical trial NCT02110706 · COMPLETED
Trial details
- NCT number
- NCT02110706
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2017-07-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.